Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration

Table 1

Baseline characteristics.

Total patients,	47
Total eyes, (%)	47
Male, (%)	20 (42.6%)
Right eye, (%)	27 (57.4%)
Age, years (±SD, range)	80.5 (±8.02, 59–98)